What's new

Human medicines European public assessment report (EPAR): Cosentyx, secukinumab, Date of authorisation: 14/01/2015, Revision: 39, Status: Authorised

Human medicines European public assessment report (EPAR): Cosentyx, secukinumab, Date of authorisation: 14/01/2015, Revision: 39, Status: Authorised

Mar 26, 2025 - 11:45
 0
Human medicines European public assessment report (EPAR): Cosentyx, secukinumab, Date of authorisation: 14/01/2015, Revision: 39, Status: Authorised
Human medicines European public assessment report (EPAR): Cosentyx, secukinumab, Date of authorisation: 14/01/2015, Revision: 39, Status: Authorised
Read More

Tags:

Previous Article

EVs now outpacing petrol cars in annual mileage

Next Article

Puma and Re&Up to collaborate on scaling circularity

Related Posts

PSUSA/00010774/202403

PSUSA/00010774/202403

Feb 9, 2025  0

Human medicines European public assessment report (EPAR): Xeljanz, tofacitinib, Date of authorisation: 22/03/2017, Date of refusal: 25/04/2013, Revision: 34, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 24, 2025  0

Veterinary medicines European public assessment report (EPAR): Prazivetin, praziquantel, Status: Opinion

Veterinary medicines European public assessment report ...

Mar 14, 2025  0